Biomarkers determination

OTHER2 trials

Sponsors

Grigore T. Popa University of Medicine and Pharmacy

Conditions

CKDCKD - Chronic Kidney DiseaseCOVID-19Cardiovascular DiseaseDiabetes (DM)DialysisEndothelial DysfunctionHeart Failure Preserved Ejection Fraction

Unknown Phase

Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2

Grigore T. Popa University of Medicine and PharmacyCardiovascular Disease, CKD, COVID-19 +3

Start: 2021-01-04End: 2024-03-31Target: 250Updated: 2022-01-21

Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients

RecruitingNCT07237451

Grigore T. Popa University of Medicine and PharmacyCKD - Chronic Kidney Disease, Diabetes (DM), Heart Failure Preserved Ejection Fraction +1

Start: 2025-01-08End: 2027-12-31Target: 200Updated: 2025-11-19

Related Papers

Long-Term Evolution of Post-COVID-19 Echocardiographic Parameters in Patients with Chronic Kidney Disease: A Prospective Comparative Observational Study

Journal of Clinical Medicine2025-03-081 citations

#5711 MYOCARDIAL PERFORMANCE EVOLUTION AT 6 MONTHS FROM COVID-19 IN CKD PATIENTS

Nephrology Dialysis Transplantation2023-06-01

The impact of COVID-19 on right ventricular function in chronic kidney disease patients

European Heart Journal2022-10-01

Long-term cardio-vascular risk assessment in chronic kidney disease and kidney transplanted patients following SARS-COV-2 disease: protocol for multi-center observational match controlled trial

BMC Nephrology2022-05-062 citations